O9: Mechanisms and Therapeutic Options in Multiple Sclerosis

author

  • Sven G Meuth University Hospital Münster, Neurology Clinic with Institute of Translational Neurology, Albert-Schweitzer-Campus 1, 48149 Münster, Germany
Abstract:

Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system associated to myelin loss and neurodegeneration. Clinically patients suffer from diverse symptoms and face the risk to become wheelchair-bound. At the moment MS is incurable, thus there is an unmet need for therapeutic options.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Therapeutic options in multiple sclerosis

Neurology® Clinical Practice 2010;75(Suppl 1):S22–S27 Care of the patient with multiple sclerosis (MS) is becoming increasingly complex, with new symptomatic therapies (e.g., dalfampridine), enhanced use of disease-modifying therapies that are potentially both more efficacious and more risky (e.g., natalizumab, rituximab) than “standard” immunomodulators, the advent of oral disease-modifying th...

full text

O 10: Multiple Sclerosis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options

Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system associated to myelin loss and neurodegeneration. Clinically patients suffer from diverse symptoms and face the risk to become wheelchair-bound. At the moment MS is incurable, thus there is an unmet need for therapeutic options. 

full text

Therapeutic options in multiple sclerosis: five new things.

Therapeutic options in multiple sclerosis: five new things. [1]

full text

Therapeutic options for systemic sclerosis.

Systemic sclerosis is a uncommon connective tissue disorder characterized by vascular damage, immune cell activation and fibrogenesis. Each of these components may respond to different therapies. Therefore, a combination strategy treating all three processes is more likely to control the disease than single agent therapy. Clinical trials have gone a long way towards defining the therapy of scle...

full text

Therapeutic Applications of Monoclonal Antibodies in Multiple Sclerosis

Despite the various therapies available, the use of monoclonal antibodies is a highly specific approach that has only recently been of interest to researchers. The properties of antibodies have led to their use in the treatment of various diseases, including cancer, Alzheimer's disease, diabetes and multiple sclerosis (MS). MS, a chronic inflammatory disease, occurs commonly in young adults. Th...

full text

o 10: multiple sclerosis: general aspects of pathophysiology, symptoms and therapeutic options

multiple sclerosis (ms) is an autoimmune disease of the central nervous system associated to myelin loss and neurodegeneration. clinically patients suffer from diverse symptoms and face the risk to become wheelchair-bound. at the moment ms is incurable, thus there is an unmet need for therapeutic options.

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 6  issue 2

pages  9- 9

publication date 2018-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023